Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014002HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10010337HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10010338HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10010597HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10013620HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10033163HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10041979HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10045030HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS10045031HBVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS30000540HIVENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TCGA Plot Options
Drug Information
GeneCACNA1C
DrugBank IDDB01373
Drug NameCalcium
Target IDBE0000430
UniProt IDQ13936
Regulation Typeligand
PubMed IDs21303162
CitationsBoda D, Giri J, Henderson D, Eisenberg B, Gillespie D: Analyzing the components of the free-energy landscape in a calcium selective ion channel by Widom's particle insertion method. J Chem Phys. 2011 Feb 7;134(5):055102. doi: 10.1063/1.3532937.
GroupsNutraceutical
Direct Classification
SMILES[Ca]
PathwaysLidocaine (Antiarrhythmic) Action Pathway; Reteplase Action Pathway; Arachidonic Acid Metabolism; Oxaprozin Action Pathway; Ardeparin Action Pathway; Heparin Action Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; Riboflavin Metabolism; Alprenolol Action Pathway; Naproxen Action Pathway; Procainamide (Antiarrhythmic) Action Pathway; Sphingolipid Metabolism; Tranexamic Acid Action Pathway; Xanthine Dehydrogenase Deficiency (Xanthinuria); Meloxicam Action Pathway; Phenprocoumon Action Pathway; Streptokinase Action Pathway; Phenylketonuria; Gaucher Disease; Fc Epsilon Receptor I Signaling in Mast Cells; Ketorolac Action Pathway; Androgen and Estrogen Metabolism; Acetylsalicylic Acid Action Pathway; Bivalirudin Action Pathway; Aprotinin Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Malate-Aspartate Shuttle; Folate Metabolism; Adenylosuccinate Lyase Deficiency
PharmGKBPA164712582
ChEMBL